CA3225678A1 - Systemes et procedes pour fournir des donnees de patient precises correspondant a des reperes de progression pour fournir des options de traitement et un suivi de resultats - Google Patents
Systemes et procedes pour fournir des donnees de patient precises correspondant a des reperes de progression pour fournir des options de traitement et un suivi de resultats Download PDFInfo
- Publication number
- CA3225678A1 CA3225678A1 CA3225678A CA3225678A CA3225678A1 CA 3225678 A1 CA3225678 A1 CA 3225678A1 CA 3225678 A CA3225678 A CA 3225678A CA 3225678 A CA3225678 A CA 3225678A CA 3225678 A1 CA3225678 A1 CA 3225678A1
- Authority
- CA
- Canada
- Prior art keywords
- fact
- patient
- progression
- candidate
- facts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 140
- 238000011282 treatment Methods 0.000 title claims description 85
- 238000003745 diagnosis Methods 0.000 claims abstract description 69
- 230000002452 interceptive effect Effects 0.000 claims abstract description 57
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 87
- 201000010099 disease Diseases 0.000 claims description 73
- 230000009467 reduction Effects 0.000 claims description 61
- 239000003550 marker Substances 0.000 claims description 42
- 206010028980 Neoplasm Diseases 0.000 claims description 37
- 230000008859 change Effects 0.000 claims description 32
- 238000012360 testing method Methods 0.000 claims description 31
- 230000036541 health Effects 0.000 claims description 19
- 208000035475 disorder Diseases 0.000 claims description 14
- 206010061289 metastatic neoplasm Diseases 0.000 claims description 14
- 239000000090 biomarker Substances 0.000 claims description 13
- 230000001394 metastastic effect Effects 0.000 claims description 11
- 238000004393 prognosis Methods 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 10
- 238000012795 verification Methods 0.000 description 32
- 230000008569 process Effects 0.000 description 30
- 201000011510 cancer Diseases 0.000 description 26
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 24
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 21
- 238000003860 storage Methods 0.000 description 19
- 238000012545 processing Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000005750 disease progression Effects 0.000 description 9
- 206010061818 Disease progression Diseases 0.000 description 8
- 102000015694 estrogen receptors Human genes 0.000 description 8
- 108010038795 estrogen receptors Proteins 0.000 description 8
- 208000037819 metastatic cancer Diseases 0.000 description 8
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000004590 computer program Methods 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 238000009121 systemic therapy Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000004941 influx Effects 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000013501 data transformation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000009397 lymphovascular invasion Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000683 nonmetastatic effect Effects 0.000 description 2
- 102000003998 progesterone receptors Human genes 0.000 description 2
- 108090000468 progesterone receptors Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 102100035348 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000012517 data analytics Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013503 de-identification Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/048—Interaction techniques based on graphical user interfaces [GUI]
- G06F3/0484—Interaction techniques based on graphical user interfaces [GUI] for the control of specific functions or operations, e.g. selecting or manipulating an object, an image or a displayed text element, setting a parameter value or selecting a range
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Human Resources & Organizations (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Economics (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Data Mining & Analysis (AREA)
- Entrepreneurship & Innovation (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tourism & Hospitality (AREA)
- Quality & Reliability (AREA)
- Operations Research (AREA)
- Marketing (AREA)
- Game Theory and Decision Science (AREA)
- Educational Administration (AREA)
- Development Economics (AREA)
- Databases & Information Systems (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Human Computer Interaction (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
L'invention concerne un système, un procédé et un support lisible par ordinateur non transitoire, pour fournir des données de patient précises correspondant à des repères de diagnostic et/ou de progression pour un patient présentant un état pathologique et/ou une maladie. L'invention concerne également des procédés et des systèmes pour fournir une interface utilisateur graphique comprenant une ligne chronologique d'informations de patient interactive.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/375,916 | 2021-07-14 | ||
| US17/375,916 US20210343420A1 (en) | 2020-01-09 | 2021-07-14 | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking |
| PCT/US2022/037017 WO2023287920A1 (fr) | 2021-07-14 | 2022-07-13 | Systèmes et procédés pour fournir des données de patient précises correspondant à des repères de progression pour fournir des options de traitement et un suivi de résultats |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3225678A1 true CA3225678A1 (fr) | 2023-01-19 |
Family
ID=84920406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3225678A Pending CA3225678A1 (fr) | 2021-07-14 | 2022-07-13 | Systemes et procedes pour fournir des donnees de patient precises correspondant a des reperes de progression pour fournir des options de traitement et un suivi de resultats |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4371132A1 (fr) |
| JP (1) | JP2024529876A (fr) |
| KR (1) | KR20240032920A (fr) |
| CN (1) | CN117981012A (fr) |
| AU (1) | AU2022311798A1 (fr) |
| CA (1) | CA3225678A1 (fr) |
| IL (1) | IL310082A (fr) |
| WO (1) | WO2023287920A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2702408C (fr) * | 2007-10-12 | 2019-08-06 | Patientslikeme, Inc. | Procede auto-ameliore d'utilisation de communautes en ligne pour predire des resultats cliniques |
| US8694335B2 (en) * | 2011-02-18 | 2014-04-08 | Nuance Communications, Inc. | Methods and apparatus for applying user corrections to medical fact extraction |
| US10783448B2 (en) * | 2015-08-07 | 2020-09-22 | Flatiron Health, Inc. | Extracting facts from unstructured data |
| US10949395B2 (en) * | 2016-03-30 | 2021-03-16 | Salesforce.Com, Inc. | Cross objects de-duplication |
-
2022
- 2022-07-13 CA CA3225678A patent/CA3225678A1/fr active Pending
- 2022-07-13 KR KR1020247004016A patent/KR20240032920A/ko unknown
- 2022-07-13 IL IL310082A patent/IL310082A/en unknown
- 2022-07-13 WO PCT/US2022/037017 patent/WO2023287920A1/fr active Application Filing
- 2022-07-13 CN CN202280060905.0A patent/CN117981012A/zh active Pending
- 2022-07-13 AU AU2022311798A patent/AU2022311798A1/en active Pending
- 2022-07-13 JP JP2024501769A patent/JP2024529876A/ja active Pending
- 2022-07-13 EP EP22842831.4A patent/EP4371132A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022311798A1 (en) | 2024-01-25 |
| CN117981012A (zh) | 2024-05-03 |
| WO2023287920A9 (fr) | 2023-12-07 |
| WO2023287920A1 (fr) | 2023-01-19 |
| KR20240032920A (ko) | 2024-03-12 |
| IL310082A (en) | 2024-03-01 |
| EP4371132A1 (fr) | 2024-05-22 |
| JP2024529876A (ja) | 2024-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12073342B2 (en) | Informatics platform for integrated clinical care | |
| Senthilkumar et al. | Big data in healthcare management: a review of literature | |
| US20200381087A1 (en) | Systems and methods of clinical trial evaluation | |
| US10902953B2 (en) | Clinical outcome tracking and analysis | |
| US8731966B2 (en) | Systems and methods for real-time data ingestion to a clinical analytics platform to generate a heat map | |
| US20210343420A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| JP6367557B2 (ja) | 臨床データ解析モジュールへの統合的なアクセスおよび臨床データ解析モジュールとの相互作用 | |
| US11984227B2 (en) | Automatically determining a medical recommendation for a patient based on multiple medical images from multiple different medical imaging modalities | |
| JP2019530098A (ja) | 協調的な変異選択及び治療合致レポートのための方法及び装置 | |
| Bigus et al. | Information technology for healthcare transformation | |
| KR102579786B1 (ko) | 임상 결과들을 개선하고 총 케어 비용을 감소시키기 위한 cna-유도 케어 | |
| US20240062885A1 (en) | Systems and methods for generating an interactive patient dashboard | |
| US20210217527A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| CA3225678A1 (fr) | Systemes et procedes pour fournir des donnees de patient precises correspondant a des reperes de progression pour fournir des options de traitement et un suivi de resultats | |
| Dighe | Electronic health record optimization for artificial intelligence | |
| US20230395241A1 (en) | Methods and systems for patient discharge management | |
| Navarro-Cerdán et al. | Effects of Comorbidities (Chronic Illness) on Hospitalization and Mortality Risks: Available to Clinicians Through an App | |
| Beyan | Single nucletide polymorphism (SNP) data integrated electronic health record (EHR) for personalized medicine |